Trends-in-Medicine has no financial connections with any pharmaceutical or medical device company. The information and opinions expressed have been compiled or arrived at from sources believed to be reliable and in good faith, but no liability is assumed for information contained in this newsletter. Copyright ©2013. No articles may be reproduced without written permission of the publisher.

Archives

FDA Advisory Committee Recommends Approval of Boston Scientific’s Watchman

ELR December 2013 Issue

Quick Takes December 29, 2013 Issue

Quick Takes December 22, 2013 Issue

American Society of Hematology

FDA Advisory Committee Does Not Recommend Approval of Sanofi/Genzyme’s Lemtrada for Multiple Sclerosis

Quick Takes December 15, 2013 Issue

ELR Highlights November 2013

Quick Takes December 8, 2013 Issue

FDA Advisory Committee Recommends Approval of Vanda’s Hetlioz for Rare Sleep Disorder

FDA Advisory Committee Recommends Approval of Biomarin’s Vimizim for Morquio A Syndrome

American College of Rheumatology

Quick Takes December 1, 2013 Issue

Obesity Week

FDA Subcommittee Discusses Pediatric Trials of Cancer Biologics

Search

Events Calendar

Categories

Get Adobe Reader

Disclaimer